WHO WE ARE

Building authentic connections to accelerate innovation and recalibrate what is possible in pursuit of better healthcare for all.

With proven financial performance and a history of collaborative connections, Ascension Ventures creates value in every sense of the word.

Ascension Ventures is a strategic healthcare venture fund and innovation catalyst with more than $1 billion in capital under management. We pioneered a healthcare ecosystem investment model that brings a strategic lens to intentional investment, creating one of the industry’s largest high-performing limited partner value creation platforms.

$1+ Billion
in capital under management
462
acute care hospitals
572,000
associates

OUR APPROACH

Our engaged community connects highly respected, values-driven healthcare systems with emerging innovators to develop scalable solutions to healthcare’s most complex challenges. We forge robust, meaningful working relationships with our portfolio company management teams, enabling us to understand their needs and goals to provide the best strategic guidance.

The work we do at Ascension Ventures generates returns to our limited partners, helping support their missions and strategic objectives. Our limited partners represent:

  • 462 acute care hospitals and other healthcare facilities
  • Coverage in 41 states and the District of Columbia
  • Approximately $96 billion in combined annual operating revenue
  • 572,000 associates

INVESTMENT CRITERIA

Our diligence process leverages the intellectual resources and insight of professionals across our limited partner base.

We serve as true partners, helping find clarity amid a complex healthcare landscape and empowering our Limited Partners to invest with impact and advance the future of healthcare. Our proven expertise enables us to put our healthcare investment acumen to work, identifying the highest-value opportunities for our partners.

Our selection process infuses performance with purpose, prioritizing partners that combine financial strength with solutions and technologies that can help improve clinical outcomes, enhance the healthcare experience and reduce waste.

Additional criteria include:

Industry
Venture and growth equity investments in healthcare information technology and services, and medical devices and diagnostics.

Investment Size
$10-$20 million in aggregate per company.

Company Stage
Early- to late-stage within three to five years of a potential liquidating event.

Adoption Potential
Sustainable competitive advantage with compelling benefits sufficient to influence market adoption.

Management Team
Established team with demonstrated relevant experience, depth and capability to build the business to scale and exit.

Other
Ascension Ventures typically requests a Board seat or Board observation rights for each portfolio company.